http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2744846-C1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_79ae6dd5bafbd2dd69035367385d754c |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G09B23-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7105 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7105 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G09B23-28 |
| filingDate | 2020-06-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2021-03-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0128194d6bff2d1c68420542e1a44397 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ddbf4b6fe368358dc5e94406998998cf http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_34bb1d0109e6bb9fc34bbf866902a1d4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6cae42eddd2991d0a7ac6edd7df36d4a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_61f37c4ff41c2ac743cf1d70da17a505 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_447b868f8c9dd2aee5b351f152654479 |
| publicationDate | 2021-03-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2744846-C1 |
| titleOfInvention | Method of treatment of acute liver failure |
| abstract | FIELD: medicine; hepatology. n SUBSTANCE: invention relates to medicine, namely to hepatology, and can be used for the treatment of acute liver failure (ARF) in an experiment, after a surgical operation, in the result of which a critical deficiency of functioning liver tissue is formed. An unsorted fraction of mononuclear bone marrow cells (BMC) is obtained from a donor rat and stored in a Custodiol solution at a temperature of 4-6 ºC for 3-18 hours. After that, total RNA (oRNA) is obtained from it and entered at once intraperitoneally and intraoperatively to an experimental animal - a rat after performing a surgical operation, at a dose of 90-110 mcg/100 g of animal weight. n EFFECT: method makes it possible to accelerate the rate, reliability and effectiveness of the treatment of severe and extremely severe forms of ARF that develop after surgical excision of critical volumes of liver tissue, by increasing the activity of the induction and regulatory effects of oRNA from freshly isolated BMC on the processes of reparative liver regeneration. n 2 cl, 2 dwg, 4 tbl |
| priorityDate | 2020-06-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 166.